Association of Systemic Diseases with Chronic Pruritus
CHRONIC PRURITUS
Abstract
Background/Aim: Pruritus is an unpleasant sensation that provokes the desire to scratch. It is one of the most common reasons why patients consult a dermatologist. Aim of this study was to determine the association of chronic pruritus with skin and systemic diseases, as well as the age and sex distribution in the studied population.
Methods: The cross-sectional study included 120 patients of both sexes who, in the period from January 2017 to January 2021, received outpatient and inpatient treatment at the Skin and Venereal Diseases Clinic of the University Clinical Centre of the Republic of Srpska diagnosed with pruritus. Through the Clinical Information System insight was gained into the medical history and other documentation of the subjects from which data were taken on the age and sex of the subjects, onset, course and duration of pruritus, daily or seasonal variations in intensity, as well as the presence of associated skin and systemic diseases.
Results: Out of a total of 120 subjects, a larger number (53.3 %) of subjects with chronic pruritus were male, and 46.7 % were female, the difference was statistically significant (p < 0.05). The analysis of the distribution of subjects according to their age revealed that the largest number of subjects (62.6 %) was over 65 years of age, while 38.4 % of subjects were under 65 years of age. The difference in the age structure was statistically significant (p < 0.05). In subjects older than 65 years pruritus was most frequently (47.3 %) associated with diabetes and in subjects under 65 years of age with skin diseases and conditions. The difference was statistically significant (p < 0.05).
Conclusion: In people aged over 65 years, pruritus is most frequently associated with systemic diseases (diabetes mellitus) and in people aged under 65 years with dermatological diseases (Dermatitis atopica).
References
Weisshaar E, Szepietowski JC, Dalgard FJ, Garcovich S, Gieler U, Giménez-Arnau AM, et al. European S2k guideline on chronic pruritus. Acta Derm Venereol 2019;99(5):469-506.
2. Whang KA, Khanna R, Thomas J, Aguh C, Kwatra SG. Racial and gender differences in the presentation of pruritus. Medicines (Basel) 2019 Sep 27;6(4):98. doi: 10.3390/medicines6040098.
3. Fett N, Haynes K, Propert KJ, Margolis DJ. Predictors of malignancy development in patients with chronic pruritus. J Dermatol Sci 2016 May;82(2):123-8.
4. Pereira MP, Ständer S. Chronic pruritus: current and emerging treatment options. Drugs 2017 Jun;77(9):999-1007.
5. Moniaga CS, Tominaga M, Takamori K. Mechanisms and management of itch in dry skin. Acta Derm Venereol 2020 Jan 15;100(2):adv00024. doi: 10.2340/00015555-3344.
6. Reich A, Ständer S, Szepietowski JC. Pruritus in the elderly. Clin Dermatol 2011 Jan-Feb;29(1):15-23.
7. Welz-Kubiak K, Reszke R, Szepietowski JC. Pruritus as a sign of systemic disease. Clin Dermatol 2019 Nov-Dec;37(6):644-56.
8. Cao T, Tey HL, Yosipovitch G. Chronic pruritus in the geriatric population. Dermatol Clin 2018 Jul;36(3):199-211.
9. Sutaria N, Adawi W, Goldberg R, Roh YS, Choi J, Kwatra SG. Itch: pathogenesis and treatment. J Am Acad Dermatol 2022 Jan;86(1):17-34.
10. Mollanazar NK, Smith PK, Yosipovitch G. Mediators of chronic pruritus in atopic dermatitis: getting the itch out? Clin Rev Allergy Immunol 2016 Dec;51(3):263-92.
11. Pavlović M, Stojanović O. [Neurophysiology of pruritus]. In: Karadaglić Đ: [Dermatology]. 2nd edition. Belgrade: Birograf Comp, 2016; pp. 303-321. Serbian.
12. Dalgard F, Svensson A, Holm JØ, Sundby J. Self-reported skin morbidity in Oslo. Associations with sociodemographic factors among adults in a cross-sectional study. Br J Dermatol 2004 Aug;151(2):452-7.
13. Umičević-Šipka S, Balaban J, Bijelić R. Association between skin manifestations and glycemic control in patients with diabetes mellitus type II. Vojnosanit pregl 2021;78(3):323-30.
14. Sani H, Abubakar AB, Bakari AG. Prevalence and pattern of skin diseases in patients with diabetes mellitus at a tertiary hospital in Northern Nigeria. Niger J Clin Pract 2020 Jul;23(7):970-4.
15. Quondamatteo F. Skin and diabetes mellitus: what do we know? Cell Tissue Res 2014 Jan;355(1):1-21.
16. Zhou P, Yang C, Zhang S, Ke ZX, Chen DX, Li YQ, et al. The imbalance of MMP-2/TIMP-2 and MMP-9/TIMP-1 contributes to collagen deposition disorder in diabetic non-injured skin. Front Endocrinol (Lausanne) 2021 Oct 27;12:734485. doi: 10.3389/fendo.2021.734485.
17. Tse R, Kesha K, Morrow P, Glenn C, Stables S. Commentary on: Kenneally M, Byard RW. Increasing methamphetamine detection in cases of early childhood fatalities. J Forensic Sci doi: 10.1111/1556-4029.14321. J Forensic Sci 2020 Jul;65(4):1384. doi: 10.1111/1556-4029.14459.
18. Agarwal P, Garg V, Karagaiah P, Szepietowski JC, Grabbe S, Goldust M. Chronic kidney disease-associated pruritus. Toxins (Basel) 2021 Jul 28;13(8):527. doi: 10.3390/toxins13080527.
19. Combs SA, Teixeira JP, Germain MJ. Pruritus in Kidney Disease. Semin Nephrol 2015 Jul; 35(4): 383-91.
20. Dawn A, Papoiu AD, Chan YH, Rapp SR, Rassette N, Yosipovitch G. Itch characteristics in atopic dermatitis: results of a web-based questionnaire. Br J Dermatol 2009 Mar;160(3):642-4.
21. Mollanazar NK, Sethi M, Rodriguez RV, Nattkemper LA, Ramsey FV, Zhao H, et al. Retrospective analysis of data from an itch center: Integrating validated tools in the electronic health record. J Am Acad Dermatol 2016 Oct;75(4):842-44.
22. Fourzali KM, Yosipovitch G. Management of itch in the elderly: a review. Dermatol Ther (Heidelb) 2019 Dec;9(4):639-53.
23. Lee HG, Stull C, Yosipovitch G. Psychiatric disorders and pruritus. Clin Dermatol 2017 May-Jun;35(3):273-80.
24. Ferm I, Sterner M, Wallengren J. Somatic and psychiatric comorbidity in patients with chronic pruritus. Acta Derm Venereol 2010 Jul; 90(4):395-400.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).